Will Teladoc Recover In 2022?
Teladoc (NYSE: TDOC) shined during the worst of the pandemic -- and through the whole year of 2020. The telehealth company reported massive gains in revenue and online medical visits. And the shares advanced 138%.
But part of the story changed this year. Not the financial picture. Teladoc continued to post increases in revenue and visits. The company even revised its outlook higher. But the stock sank about 50%. Why? Investors worried patients would eventually abandon virtual medical visits and return to their local doctor's office. So far that hasn't happened. And clues show us it probably won't. So now, a few days before 2022, you might be wondering: Will Teladoc shares rebound next year? Let's take a look.
Image source: Getty Images.
Source Fool.com
